Elsevier Inc.

SHERPA: Unknown

People

  1. Curran
    Curran
  2. Kernan
    Kernan
  3. O'Reilly
    O'Reilly
  4. Scaradavou
    Scaradavou
  5. Kobos
    Kobos
  6. Boelens
    Boelens
  7. Giralt
    Giralt
  8. Cancio
    Cancio
  9. Ruggiero
    Ruggiero
  10. Sadelain
    Sadelain

Groups

  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. GSK Faculty (10)
  4. Pediatrics, Department of (10)
  5. Stem Cell Transplantation and Cellular Therapy Service (10)
  6. Immunology Program Faculty (9)
  7. Sloan Kettering Institute Faculty (9)
  8. Tow Center for Developmental Oncology (TCDO) (8)
  9. Hematologic Malignancies, Division of (6)
  10. Adult Leukemia (4)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Biology of Blood and Marrow Transplantation"
  3. "Kevin Curran"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Center for Hematologic Malignancies (10)
  2. Department of Medicine (10)
  3. GSK Faculty (10)
  4. Pediatrics, Department of (10)
  5. Stem Cell Transplantation and Cellular Therapy Service (10)
  6. Immunology Program Faculty (9)

More Groups

People
  1. Kevin Curran (10)
  2. Farid Boulad (8)
  3. Nancy Kernan (8)
  4. Richard O'Reilly (8)
  5. Susan Prockop (8)
  6. Andromachi Scaradavou (7)

More People

Years
  1. 2020 (3)
  2. 2019 (2)
  3. 2018 (1)
  4. 2016 (1)
  5. 2015 (1)
  6. 2014 (2)
Publications
  1. Biology of Blood and Marrow Transplantation (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early CD4+ T cell reconstruction as predictor for outcomes after allogeneic hematopoietic cell transplantation in pediatric and young adult patients: A validation cohort analyses
    Meeting Abstract

    Van Roessel, I.; Prockop, S. E.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; Cancio, M.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
    Review

    Lee, D. W.; Santomasso, B. D.; Locke, F. L.; Ghobadi, A.; Turtle, C. J.; Brudno, J. N.; Maus, M. V.; Park, J. H.; Mead, E.; Pavletic, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Building a CAR garage: Preparing for the delivery of commercial CAR T cell products at Memorial Sloan Kettering Cancer Center
    Journal Article

    Perica, K.; Curran, K. J.; Brentjens, R. J.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease
    Meeting Abstract

    Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation (HSCT) for non malignant hematologic disorders (NMHD), using a chemotherapy-only cytoreductive regimen and T-cell depleted grafts from alternative donors
    Meeting Abstract

    Boulad, F.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Lehrman, R.; Ruggiero, J. M.; Curran, K.; Kobos, R.; O'reilly, R.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save